| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 473.51 +7.50% on 02/27/25 |
Period Open: 480.35
| 519.68 -2.05% on 03/14/25 | +28.69 (+5.97%) since 02/25/25 |
| 3-Month | 397.24 +28.14% on 01/13/25 |
Period Open: 408.18
| 519.68 -2.05% on 03/14/25 | +100.86 (+24.71%) since 12/24/24 |
| 52-Week | 377.85 +34.72% on 12/19/24 |
Period Open: 416.03
| 519.88 -2.09% on 11/08/24 | +93.01 (+22.36%) since 03/25/24 |
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this....
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility .
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable. The demand for healthcare products and services typically holds up very well regardless...
Check out these three stocks with balance sheets that have a case for being among the strongest in the entire stock market.
Shares of Vertex Pharmaceuticals Incorporated VRTX rose 2.4% on its cystic fibrosis drug Alyftrek getting approval in the United Kingdom.Shares of Tesla, Inc. TSLA plummeted 15.4% on the broad-based stock...
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right...
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX) . The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained...
Beverages, Alcohol, and Tobacco Stocks Q4 In Review: MGP Ingredients (NASDAQ:MGPI) Vs Peers
While on the surface BUD stock seems liable for a severe correction, it could be one of the better investments in the new geopolitical paradigm.
BUD stock is moving higher after posting record full-year revenue on lower volume; solid fundamentals suggest the stock may have room to run higher
Anheuser-Busch (NYSE:BUD) Reports Q4 Results
Why Are Anheuser-Busch (BUD) Shares Soaring Today
BUD earnings call for the period ending December 31, 2024.
Wednesday, February 26, 2025Pre-market futures are picking themselves up again this morning, with the Dow adding +126 points, the S&P 500 +33 points, the Nasdaq +178 and the small-cap Russell 2000 is up...
Pre-market futures are picking themselves up again this morning, with the Dow adding +126 points, the S&P 500 +33 points, the Nasdaq +178 and the small-cap Russell 2000 is up +10 points. Over the past...
Celsius Holdings' stock surged after a strong earnings report and a major acquisition, signaling a potential resurgence for the energy drink maker.
/CNW/ - Since 1847, Labatt has been making beer in Canada with more than 70 brands produced at six locations across the country. With 3,500 employees from...
Beverages, Alcohol, and Tobacco Stocks Q4 In Review: MGP Ingredients (NASDAQ:MGPI) Vs Peers
While on the surface BUD stock seems liable for a severe correction, it could be one of the better investments in the new geopolitical paradigm.
BUD stock is moving higher after posting record full-year revenue on lower volume; solid fundamentals suggest the stock may have room to run higher
Anheuser-Busch (NYSE:BUD) Reports Q4 Results
Why Are Anheuser-Busch (BUD) Shares Soaring Today
BUD earnings call for the period ending December 31, 2024.
Wednesday, February 26, 2025Pre-market futures are picking themselves up again this morning, with the Dow adding +126 points, the S&P 500 +33 points, the Nasdaq +178 and the small-cap Russell 2000 is up...
Pre-market futures are picking themselves up again this morning, with the Dow adding +126 points, the S&P 500 +33 points, the Nasdaq +178 and the small-cap Russell 2000 is up +10 points. Over the past...
Celsius Holdings' stock surged after a strong earnings report and a major acquisition, signaling a potential resurgence for the energy drink maker.
/CNW/ - Since 1847, Labatt has been making beer in Canada with more than 70 brands produced at six locations across the country. With 3,500 employees from...
| 3rd Resistance Point | 521.90 |
| 2nd Resistance Point | 517.30 |
| 1st Resistance Point | 513.17 |
| Last Price | 509.04 |
| 1st Support Level | 504.45 |
| 2nd Support Level | 499.85 |
| 3rd Support Level | 495.72 |
| 52-Week High | 519.88 |
| Last Price | 509.04 |
| Fibonacci 61.8% | 465.62 |
| Fibonacci 50% | 448.86 |
| Fibonacci 38.2% | 432.11 |
| 52-Week Low | 377.85 |
Please check your inbox for a link to activate your My Barchart Account.
If you do not receive the email within a few minutes check your spam folder or contact our support team for assistance.
